The Clorox Company $CLX Shares Acquired by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC increased its stake in The Clorox Company (NYSE:CLX) by 1.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,058 shares of the company’s stock after acquiring an additional 408 shares during the period. Nisa Investment Advisors LLC’s holdings in Clorox were worth $3,249,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in Clorox by 0.4% in the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock valued at $2,293,135,000 after buying an additional 65,924 shares in the last quarter. Northern Trust Corp raised its stake in Clorox by 2.3% in the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock valued at $225,133,000 after buying an additional 34,655 shares in the last quarter. Invesco Ltd. raised its stake in Clorox by 7.4% in the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock valued at $200,512,000 after buying an additional 94,371 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Clorox by 3.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock valued at $170,406,000 after buying an additional 41,485 shares in the last quarter. Finally, Hsbc Holdings PLC raised its stake in Clorox by 118.8% in the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after buying an additional 589,544 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

NYSE CLX opened at $110.73 on Thursday. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The Clorox Company has a 52-week low of $110.61 and a 52-week high of $171.37. The business’s 50-day moving average price is $120.78 and its 200 day moving average price is $126.29. The firm has a market cap of $13.48 billion, a P/E ratio of 16.98, a P/E/G ratio of 0.96 and a beta of 0.52.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. During the same quarter last year, the company posted $1.82 earnings per share. The business’s revenue was up 4.5% on a year-over-year basis. On average, equities research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.5%. Clorox’s dividend payout ratio (DPR) is currently 76.07%.

Insider Activity

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.63% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

CLX has been the topic of a number of analyst reports. Citigroup cut their price target on Clorox from $135.00 to $130.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft cut their price target on Clorox from $135.00 to $128.00 and set a “hold” rating on the stock in a research note on Monday, October 13th. BNP Paribas Exane dropped their price objective on Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a report on Friday, October 17th. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. Finally, TD Cowen dropped their price objective on Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a report on Wednesday, October 1st. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $130.20.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.